Sunday, August 02, 2020 11:28:22 PM
They own the rights to the patent yes they do. Check back in the filings. “
Well that was wrong. Gpft does not own the IP by any stretch. The small pharma is the patent holder and is purportedly licensing out this tech to gpft for 100% of USA .All of this reported by gpft not Zylo therapeutics and no 8k accompanied any of it. If zylo has the nutflush for smokeless Thc delivery then they would be idiotic to get in bed with only one weak otc company years away from profitability... unless of course gpft forked over a giant chunk of change. I’ve seen the books and didn’t to see any 100M licensing fee.
The Q will be more of the same. Mounting losses and unsustainable cash combustion. COVID will come in handy and another excuse!
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM